Those of you who read our newsletter and visit our
website know that research is a major focus of our
organization. We have provided financial support
for various research studies throughout the years.
Typically, researchers have approached us with
requests for projects which they feel will help identify
improved treatments for MSUD. If the board and our
medical advisors agree, we provide the support.
The Strom laboratory at the Karolinska Institute in
Sweden has pioneered the use of cellular therapy
to treat liver disease, first with the transplantation
of human liver cells to correct liver disease and
later in the development of a stem cell from
human placenta that functions as a liver cell when
transplanted. Both of those endeavours continue in
New treatments are greatly needed to improve the quality
of life for people with maple syrup urine disease (MSUD).
In order for progress to be made, however, we need to
really understand how the disease works and identify
opportunities to disrupt and correct the faulty metabolic
process of MSUD.